Overview

Effect of Age on Latanoprost 0.005% in Patients With Glaucoma

Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
Latanoprost is a commonly used treatment for glaucoma. Because of its mechanism of action, it is plausible that the age of a patient using the medication may affect its efficacy and time of onset. We are going to study the effectiveness of Latanoprost in people of different ages, to see if it changes based on the age of the patient.
Phase:
Phase 4
Details
Lead Sponsor:
Yale University
Collaborator:
Pfizer
Treatments:
Latanoprost